Obliterative airway remodeling: Molecular evidence for shared pathways in transplanted and native lungs

American Journal of Pathology

Volumn 178, Issue 2, 2011, Pages 599-608

  Jonigk, Danny ^a   Merk, Marlene ^a   Hussein, Kais ^a   Maegel, Lavinia ^a   Theophile, Katharina ^a   Muth, Michaela ^a   Lehmann, Ulrich ^a   Bockmeyer, Clemens L ^a   Mengel, Michael ^b   Gottlieb, Jens ^a   Welte, Tobias ^a   Haverich, Axel ^a   Golpon, Heiko ^a   Kreipe, Hans ^a   Laenger, Florian ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 9; CALDESMON; CD45 ANTIGEN; CD68 ANTIGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; DESMIN; ENDOTHELIN 1; GELATINASE B; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; RANTES; SMAD PROTEIN; SMOOTH MUSCLE ACTIN; THROMBOSPONDIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2;

AIRWAY REMODELING; ARTICLE; BRONCHIOLE; BRONCHIOLITIS OBLITERANS; CELL INFILTRATION; CLINICAL ARTICLE; COMPARATIVE STUDY; DISEASE ASSOCIATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LASER MICRODISSECTION; LUNG FIBROSIS; LUNG TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 79951816993     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.10.032     Document Type: Article

References (38)

1. Bergeron C, Al-Ramli W, Hamid Q: Remodeling in asthma. Proc Am Thorac Soc 2009, 6:301-305
2. Sato M, Liu M, Anraku M, Ogura T, D'Cruz G, Alman BA, Waddell TK, Kim E, Zhang L, Keshavjee S: Allograft airway fibrosis in the pulmonary milieu: a disorder of tissue remodeling. Am J Transplant 2008, 8:517-528 (Pubitemid 351287538)
3. Belperio JA, Weigt SS, Fishbein MC, Lynch JP III: Chronic lung allograft rejection: mechanisms and therapy. Proc Am Thorac Soc 2009, 6:108-121
4. Sara AG, Hamdan AJ, Hanaa B, Nawaz KA: Bronchiolitis obliterans organizing pneumonia: pathogenesis, clinical features, imaging and therapy review. Ann Thorac Med 2008, 3:67-75
5. Sato M, Keshavjee S: Bronchiolitis obliterans syndrome: alloimmune-dependent and -independent injury with aberrant tissue remodeling. Semin Thorac Cardiovasc Surg 2008, 20:173-182
6. Eyden B: The myofibroblast: phenotypic characterization as a pre-requisite to understanding its functions in translational medicine. J Cell Mol Med 2008, 12:22-37
7. Brocker V, Langer F, Fellous TG, Mengel M, Brittan M, Bredt M, Milde S, Welte T, Eder M, Haverich A, Alison MR, Kreipe H, Lehmann U: Fibroblasts of recipient origin contribute to bronchiolitis obliterans in human lung transplants. Am J Respir Crit Care Med 2006, 173:1276-1282 (Pubitemid 43848400)
8. Pegorier S, Campbell GA, Kay AB, Lloyd CM: Bone morphogenetic protein (BMP)-4 and BMP-7 regulate differentially transforming growth factor (TGF)-beta1 in normal human lung fibroblasts (NHLF). Respir Res 2010, 11:85
9. Ward C, De Soyza A, Fisher AJ, Pritchard G, Forrest I, Corris P: A descriptive study of small airway reticular basement membrane thickening in clinically stable lung transplant recipients. J Heart Lung Transplant 2005, 24:533-537 (Pubitemid 40693874)
10. Wynn TA: Cellular and molecular mechanisms of fibrosis. J Pathol 2008, 214:199-210
11. Swigris JJ, Brown KK: The role of endothelin-1 in the pathogenesis of idiopathic pulmonary fibrosis 2010, BioDrugs 24:49-54
12. Chen LJ, Li WD, Li SF, Su XW, Lin GY, Huang YJ, Yan GM: Bleomycin induces upregulation of lysyl oxidase in cultured human fetal lung fibroblasts. Acta Pharmacol Sin 2010, 31:554-559
13. Kakizaki T, Kohno M, Watanabe M, Tajima A, Izumi Y, Miyasho T, Tasaka S, Fukunaga K, Maruyama I, Ishizaka A, Kobayashi K: Exacerbation of bleomycin-induced injury and fibrosis by pneumonectomy in the residual lung of mice. J Surg Res 2009, 154:336-344
14. Weiskirchen R, Meurer SK, Gressner OA, Herrmann J, Borkham- Kamphorst E, Gressner AM: BMP-7 as antagonist of organ fibrosis. Front Biosci 2009, 14:4992-5012
15. Yamashita M, Yamauchi K, Chiba R, Iwama N, Date F, Shibata N, Kumagai H, Risteli J, Sato S, Takahashi T, Ono M: The definition of fibrogenic processes in fibroblastic foci of idiopathic pulmonary fibrosis based on morphometric quantification of extracellular matrices. Hum Pathol 2009, 40:1278-1287
16. Jonigk D, Theophile K, Hussein K, Bock O, Lehmann U, Bockmeyer CL, Gottlieb J, Fischer S, Simon A, Welte T, Maegel L, Kreipe H, Laenger F: Obliterative airway remodelling in transplanted and nontransplanted lungs. Virchows Arch 2010, 457:369-380
17. Verleden GM, Vos R, DE Vleeschauwer SI, Willems-Widyastuti A, Verleden SE, Dupont LJ, Van Raemdonck DE, Vanaudenaerde BM: Obliterative bronchiolitis following lung transplantation: from old to new concepts? Transpl Int 2009, 22:771-779
18. Jonigk D, Lehmann U, Stuht S, Wilhelmi M, Haverich A, Kreipe H, Mengel M: Recipient-derived neoangiogenesis of arterioles and lymphatics in quilty lesions of cardiac allografts. Transplantation 2007, 84:1335-1342 (Pubitemid 351339322)
19. Theophile K, Jonigk D, Kreipe H, Bock O: Amplification of mRNA from laser-microdissected single or clustered cells in formalin-fixed and paraffin-embedded tissues for application in quantitative real-time PCR. Diagn Mol Pathol 2008, 17:101-106
20. Bock O, Muth M, Theophile K, Winter M, Hussein K, Busche G, Kroger N, Kreipe H: Identification of new target molecules PTK2. TGFBR2 and CD9 overexpressed during advanced bone marrow remodelling in primary myelofibrosis. Br J Haematol 2009, 146:510-520
21. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408 (Pubitemid 34164012)
22. Panoskaltsis-Mortari A, Tram KV, Price AP, Wendt CH, Blazar BR: A new murine model for bronchiolitis obliterans post-bone marrow transplant. Am J Respir Crit Care Med 2007, 176:713-723 (Pubitemid 47503080)
23. Krupnick AS, Lin X, Li W, Okazaki M, Lai J, Sugimoto S, Richardson SB, Kornfeld CG, Garbow JR, Patterson GA, Gelman AE, Kreisel D: Orthotopic mouse lung transplantation as experimental methodology to study transplant and tumor biology. Nat Protoc 2009, 4:86-93
24. Chen H, Zhuang F, Liu YH, Xu B, Del Moral P, Deng W, Chai Y, Kolb M, Gauldie J, Warburton D, Moses HL, Shi W: TGF-beta receptor II in epithelia versus mesenchyme plays distinct roles in the developing lung. Eur Respir J 2008, 32:285-295
25. Ross B, D'Orleans-Juste P, Giaid A: Potential role of endothelin-1 in pulmonary fibrosis: from the bench to the clinic. Am J Respir Cell Mol Biol 2010, 42:16-20
26. Yang K, Palm J, Konig J, Seeland U, Rosenkranz S, Feiden W, Rube C, Rube CE: Matrix-metallo-proteinases and their tissue inhibitors in radiation-induced lung injury. Int J Radiat Biol 2007, 83:665-676 (Pubitemid 47345865)
27. Chen P, McGuire JK, Hackman RC, Kim KH, Black RA, Poindexter K, Yan W, Liu P, Chen AJ, Parks WC, Madtes DK: Tissue inhibitor of metalloproteinase-1 moderates airway re-epithelialization by regulating matrilysin activity. Am J Pathol 2008, 172:1256-1270 (Pubitemid 351671539)
28. Morrell NW: Role of bone morphogenetic protein receptors in the development of pulmonary arterial hypertension. Adv Exp Med Biol 661:251-264
29. Di Bernardo MC, Matakidou A, Eisen T, Houlston RS: Plasminogen activator inhibitor variants PAI-1 A15T and PAI-2 S413C influence lung cancer prognosis. Lung Cancer 2009, 65:237-241
30. Kucharewicz I, Mogielnicki A, Kasacka I, Buczko W, Bodzenta-Lukaszyk A: Plasmin system regulation in an ovalbumin-induced rat model of asthma. Int Arch Allergy Immunol 2008, 147:190-196
31. Yang YL, Liu YS, Chuang LY, Guh JY, Lee TC, Liao TN, Hung MY, Chiang TA: Bone morphogenetic protein-2 antagonizes renal interstitial fibrosis by promoting catabolism of type I transforming growth factor-beta receptors. Endocrinology 2009, 150:727-740
32. Myllarniemi M, Vuorinen K, Pulkkinen V, Kankaanranta H, Aine T, Salmenkivi K, Keski-Oja J, Koli K, Kinnula V: Gremlin localization and expression levels partially differentiate idiopathic interstitial pneumonia severity and subtype. J Pathol 2008, 214:456-463 (Pubitemid 351340565)
33. Bock O, Hoftmann J, Theophile K, Hussein K, Wiese B, Schlue J, Kreipe H: Bone morphogenetic proteins are overexpressed in the bone marrow of primary myelofibrosis and are apparently induced by fibrogenic cytokines. Am J Pathol 2008, 172:951-960 (Pubitemid 351519992)
34. Liu SB, Hu PZ, Hou Y, Li P, Cao W, Tian Q: Recombinant human bone morphogenetic protein-2 promotes the proliferation of mesenchymal stem cells in vivo and in vitro. Chin Med J (Engl) 2009, 122:839-843
35. Costello CM, Cahill E, Martin F, Gaine S, McLoughlin P: Role of gremlin in the lung: development and disease. Am J Respir Cell Mol Biol 42:517-523
36. Gosselink JV, Hayashi S, Elliott WM, Xing L, Chan B, Yang L, Wright C, Sin D, Pare PD, Pierce JA, Pierce RA, Patterson A, Cooper J, Hogg JC: Differential expression of tissue repair genes in the pathogenesis of COPD. Am J Respir Crit Care Med 2010, 181:1329-1335
37. Ide M, Ishii H, Mukae H, Iwata A, Sakamoto N, Kadota J, Kohno S: High serum levels of thrombospondin-1 in patients with idiopathic interstitial pneumonia. Respir Med 2008, 102:1625-1630
38. Crosby LM, Waters CM: Epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol 2010, 298:L715-L731